Advanced Medical Solutions Group (LSE:AMS) Margin of Safety % (DCF FCF Based) : -1,546.15% (As of Jun. 10, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Advanced Medical Solutions Group Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2024-06-10), Advanced Medical Solutions Group's Predictability Rank is 2-Stars. Advanced Medical Solutions Group's intrinsic value calculated from the Discounted FCF model is £1.08 and current share price is £2.14. Consequently,

Advanced Medical Solutions Group's Margin of Safety % (DCF FCF Based) using Discounted FCF model is -1,546.15%.

Competitive Comparison of Advanced Medical Solutions Group's Margin of Safety % (DCF FCF Based)

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Medical Solutions Group's Margin of Safety % (DCF FCF Based) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's Margin of Safety % (DCF FCF Based) falls into.

Advanced Medical Solutions Group Margin of Safety % (DCF FCF Based) Calculation

Advanced Medical Solutions Group's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)	=	(Intrinsic Value: DCF (FCF Based)	-	Current Price)	/	Intrinsic Value: DCF (FCF Based)
	=	(0.13	-	2.14)	/	0.13
	=	-1,546.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

Advanced Medical Solutions Group Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Advanced Medical Solutions Group's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Medical Solutions Group (LSE:AMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Medical Solutions Group PLC (LSE:AMS) » Definitions » Margin of Safety % (DCF FCF Based)

Comparable Companies

Traded in Other Exchanges

AMS.GB:UK AQA:Germany

Address

Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT

Website

https://www.admedsol.com

U.K.-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.